Rabat – Italian pharmaceutical and Nutraceutical Company Pharmanutra has signed a new agreement to bring its health products to Morocco. This makes Morocco one of the latest countries, including Bahrain and Peru, to welcome the nutritional supplements and the medical devices of Pharmanutra.
The sales agreement in Morocco was signed with Alcantara Pharmaceuticals last September. Registration is now underway for three Pharmanutra products: Sideral, Sideral Gocce and Apportal, said Pharmanutra in a press release.
These products are expected to be available from next year, “in one of the leading economies in Africa,” added the explanation.
After signing the new contracts in Morocco, Bahrain and Peru, the pharmaceutical company has expanded its presence to 88 foreign countries.
“These are important figures that are achieved in a little more than ten years of international activity of the group, which makes it even more meaningful,” said Carlo Volpi, CEO of Pharanutra.
“It is clear that the main difference in the scientific value of our products is the result of exceptional work by our research and development department,” added Volpi.
The expansion is part of Pharmanutra’s strategy to expand its presence worldwide and continue to concentrate on quality, science and innovation, the company said.
Pharmanutra specializes in iron -based Additions And medical products that help with muscle and joint health.
The company was founded in 2003 by Andrea and Roberto Lacorte.
